06/28/2013 01:00 p.m. - 02:00 p.m. EDT
Corporate Finance | Capital Markets, New Products, Banking + Financial Services, and Financial Institutions + Financial Services
For presentation materials, click here.
Financial institutions in Europe and the US are considering a range of products to address their funding needs. It's a difficult task, as it's still not known which products will receive beneficial regulatory capital treatment. National regulators also have provided guidance on additional or so-called buffer capital, as well as contingent capital products, commonly referred to as CoCos.
European banks have recently issued contingent capital products and these issuances face an uncertain regulatory framework, and evolving market practice. This webcast will discuss these considerations and focus on:
WestLegalEdcenter will offer CLE credit.
©1996-2018 Morrison & Foerster LLP. All rights reserved.